France· FR:60058620
LYNPARZA 150 mg, comprimés pelliculés
A medicinal product containing olaparib, registered in France by ASTRAZENECA AB, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OLAPARIB
- Manufacturer
- ASTRAZENECA AB
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093014421314 plaquettes aluminium de 8 comprimés (emballage multiple : 2 x 56)EUR 3.98
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olaparib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLYNPARZAAstraZeneca AB, Södertälje
- SwitzerlandLynparza 150 mg, FilmtablettenAstraZeneca AG
- FinlandLynparzaOrifarm Oy
- United StatesLynparzaAstraZeneca Pharmaceuticals LP
- NetherlandsLynparza 150 mg filmomhulde tablettenAstraZeneca AB (Kvarnbergagatan)
- NorwayLynparzaAstraZeneca AB (2)
- PolandLynparzaAstraZeneca AB
- SwedenLynparza 150 mg Filmdragerad tablettAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lynparza
- Liechtenstein · Lynparza
- Norway · Lynparza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc21c8c7-d2b7-4bcd-9162-94751b0534ed GET /v1/drugs/bc21c8c7-d2b7-4bcd-9162-94751b0534ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60058620",
"date_amm": "2018-05-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/959",
"substance": "OLAPARIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about olaparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.